カテゴリー： 世界, 医療/バイオ, QYResearch

アジュバントペプチドの世界市場インサイト・予測（～2028年）

【英語タイトル】Global Adjuvant Peptide Market Insights, Forecast to 2028

QYResearchが出版した調査資料（QY22JLX09213）・商品コード：QY22JLX09213
・発行会社（調査会社）：QYResearch
・発行日：2022年7月（※2025年版があります。お問い合わせください。）
・ページ数：75
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD4,900 ⇒換算￥744,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD7,350 ⇒換算￥1,117,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD9,800 ⇒換算￥1,489,600見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

COVID-19のパンデミックにより、アジュバントペプチドのグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にアジュバントペプチドの世界市場のxxx％を占める「95%以上」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「科学研究」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
アジュバントペプチドの中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのアジュバントペプチド市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

アジュバントペプチドのグローバル主要企業には、Peptide Institute、Vivitideなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

アジュバントペプチド市場は、種類と用途によって区分されます。世界のアジュバントペプチド市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
95%以上、98%以上

【用途別セグメント】
科学研究、医療、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- アジュバントペプチド製品概要
- 種類別市場（95%以上、98%以上）
- 用途別市場（科学研究、医療、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界のアジュバントペプチド販売量予測2017-2028
- 世界のアジュバントペプチド売上予測2017-2028
- アジュバントペプチドの地域別販売量
- アジュバントペプチドの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別アジュバントペプチド販売量
- 主要メーカー別アジュバントペプチド売上
- 主要メーカー別アジュバントペプチド価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（95%以上、98%以上）
- アジュバントペプチドの種類別販売量
- アジュバントペプチドの種類別売上
- アジュバントペプチドの種類別価格
・用途別市場規模（科学研究、医療、その他）
- アジュバントペプチドの用途別販売量
- アジュバントペプチドの用途別売上
- アジュバントペプチドの用途別価格
・北米市場
- 北米のアジュバントペプチド市場規模（種類別、用途別）
- 主要国別のアジュバントペプチド市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパのアジュバントペプチド市場規模（種類別、用途別）
- 主要国別のアジュバントペプチド市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋のアジュバントペプチド市場規模（種類別、用途別）
- 主要国別のアジュバントペプチド市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米のアジュバントペプチド市場規模（種類別、用途別）
- 主要国別のアジュバントペプチド市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカのアジュバントペプチド市場規模（種類別、用途別）
- 主要国別のアジュバントペプチド市場規模（トルコ、サウジアラビア）
・企業情報
Peptide Institute、Vivitide
・産業チェーン及び販売チャネル分析
- アジュバントペプチドの産業チェーン分析
- アジュバントペプチドの原材料
- アジュバントペプチドの生産プロセス
- アジュバントペプチドの販売及びマーケティング
- アジュバントペプチドの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- アジュバントペプチドの産業動向
- アジュバントペプチドのマーケットドライバー
- アジュバントペプチドの課題
- アジュバントペプチドの阻害要因
・主な調査結果

Market Analysis and Insights: Global Adjuvant Peptide Market
The global Adjuvant Peptide market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Above 95% accounting for % of the Adjuvant Peptide global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Scientific Research segment is altered to an % CAGR throughout this forecast period.
China Adjuvant Peptide market size is valued at US$ million in 2021, while the North America and Europe Adjuvant Peptide are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Adjuvant Peptide landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Adjuvant Peptide market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Adjuvant Peptide market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Adjuvant Peptide market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Adjuvant Peptide market.
Global Adjuvant Peptide Scope and Market Size
Adjuvant Peptide market is segmented by players, region (country), by Purity and by Application. Players, stakeholders, and other participants in the global Adjuvant Peptide market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Purity and by Application for the period 2017-2028.
Segment by Purity
Above 95%
Above 98%
Segment by Application
Scientific Research
Medical
Others
By Company
Peptide Institute
Vivitide
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

❖ レポートの目次 ❖

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Purity
1.2.1 Global Adjuvant Peptide Market Size Growth Rate by Purity, 2017 VS 2021 VS 2028
1.2.2 Above 95%
1.2.3 Above 98%
1.3 Market by Application
1.3.1 Global Adjuvant Peptide Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Scientific Research
1.3.3 Medical
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Adjuvant Peptide Market Perspective (2017-2028)
2.2 Adjuvant Peptide Growth Trends by Region
2.2.1 Adjuvant Peptide Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Adjuvant Peptide Historic Market Size by Region (2017-2022)
2.2.3 Adjuvant Peptide Forecasted Market Size by Region (2023-2028)
2.3 Adjuvant Peptide Market Dynamics
2.3.1 Adjuvant Peptide Industry Trends
2.3.2 Adjuvant Peptide Market Drivers
2.3.3 Adjuvant Peptide Market Challenges
2.3.4 Adjuvant Peptide Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Adjuvant Peptide Players by Revenue
3.1.1 Global Top Adjuvant Peptide Players by Revenue (2017-2022)
3.1.2 Global Adjuvant Peptide Revenue Market Share by Players (2017-2022)
3.2 Global Adjuvant Peptide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Adjuvant Peptide Revenue
3.4 Global Adjuvant Peptide Market Concentration Ratio
3.4.1 Global Adjuvant Peptide Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Adjuvant Peptide Revenue in 2021
3.5 Adjuvant Peptide Key Players Head office and Area Served
3.6 Key Players Adjuvant Peptide Product Solution and Service
3.7 Date of Enter into Adjuvant Peptide Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Adjuvant Peptide Breakdown Data by Purity
4.1 Global Adjuvant Peptide Historic Market Size by Purity (2017-2022)
4.2 Global Adjuvant Peptide Forecasted Market Size by Purity (2023-2028)
5 Adjuvant Peptide Breakdown Data by Application
5.1 Global Adjuvant Peptide Historic Market Size by Application (2017-2022)
5.2 Global Adjuvant Peptide Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Adjuvant Peptide Market Size (2017-2028)
6.2 North America Adjuvant Peptide Market Size by Purity
6.2.1 North America Adjuvant Peptide Market Size by Purity (2017-2022)
6.2.2 North America Adjuvant Peptide Market Size by Purity (2023-2028)
6.2.3 North America Adjuvant Peptide Market Share by Purity (2017-2028)
6.3 North America Adjuvant Peptide Market Size by Application
6.3.1 North America Adjuvant Peptide Market Size by Application (2017-2022)
6.3.2 North America Adjuvant Peptide Market Size by Application (2023-2028)
6.3.3 North America Adjuvant Peptide Market Share by Application (2017-2028)
6.4 North America Adjuvant Peptide Market Size by Country
6.4.1 North America Adjuvant Peptide Market Size by Country (2017-2022)
6.4.2 North America Adjuvant Peptide Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Adjuvant Peptide Market Size (2017-2028)
7.2 Europe Adjuvant Peptide Market Size by Purity
7.2.1 Europe Adjuvant Peptide Market Size by Purity (2017-2022)
7.2.2 Europe Adjuvant Peptide Market Size by Purity (2023-2028)
7.2.3 Europe Adjuvant Peptide Market Share by Purity (2017-2028)
7.3 Europe Adjuvant Peptide Market Size by Application
7.3.1 Europe Adjuvant Peptide Market Size by Application (2017-2022)
7.3.2 Europe Adjuvant Peptide Market Size by Application (2023-2028)
7.3.3 Europe Adjuvant Peptide Market Share by Application (2017-2028)
7.4 Europe Adjuvant Peptide Market Size by Country
7.4.1 Europe Adjuvant Peptide Market Size by Country (2017-2022)
7.4.2 Europe Adjuvant Peptide Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Adjuvant Peptide Market Size (2017-2028)
8.2 Asia-Pacific Adjuvant Peptide Market Size by Purity
8.2.1 Asia-Pacific Adjuvant Peptide Market Size by Purity (2017-2022)
8.2.2 Asia-Pacific Adjuvant Peptide Market Size by Purity (2023-2028)
8.2.3 Asia-Pacific Adjuvant Peptide Market Share by Purity (2017-2028)
8.3 Asia-Pacific Adjuvant Peptide Market Size by Application
8.3.1 Asia-Pacific Adjuvant Peptide Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Adjuvant Peptide Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Adjuvant Peptide Market Share by Application (2017-2028)
8.4 Asia-Pacific Adjuvant Peptide Market Size by Region
8.4.1 Asia-Pacific Adjuvant Peptide Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Adjuvant Peptide Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Adjuvant Peptide Market Size (2017-2028)
9.2 Latin America Adjuvant Peptide Market Size by Purity
9.2.1 Latin America Adjuvant Peptide Market Size by Purity (2017-2022)
9.2.2 Latin America Adjuvant Peptide Market Size by Purity (2023-2028)
9.2.3 Latin America Adjuvant Peptide Market Share by Purity (2017-2028)
9.3 Latin America Adjuvant Peptide Market Size by Application
9.3.1 Latin America Adjuvant Peptide Market Size by Application (2017-2022)
9.3.2 Latin America Adjuvant Peptide Market Size by Application (2023-2028)
9.3.3 Latin America Adjuvant Peptide Market Share by Application (2017-2028)
9.4 Latin America Adjuvant Peptide Market Size by Country
9.4.1 Latin America Adjuvant Peptide Market Size by Country (2017-2022)
9.4.2 Latin America Adjuvant Peptide Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Adjuvant Peptide Market Size (2017-2028)
10.2 Middle East & Africa Adjuvant Peptide Market Size by Purity
10.2.1 Middle East & Africa Adjuvant Peptide Market Size by Purity (2017-2022)
10.2.2 Middle East & Africa Adjuvant Peptide Market Size by Purity (2023-2028)
10.2.3 Middle East & Africa Adjuvant Peptide Market Share by Purity (2017-2028)
10.3 Middle East & Africa Adjuvant Peptide Market Size by Application
10.3.1 Middle East & Africa Adjuvant Peptide Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Adjuvant Peptide Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Adjuvant Peptide Market Share by Application (2017-2028)
10.4 Middle East & Africa Adjuvant Peptide Market Size by Country
10.4.1 Middle East & Africa Adjuvant Peptide Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Adjuvant Peptide Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Peptide Institute
11.1.1 Peptide Institute Company Details
11.1.2 Peptide Institute Business Overview
11.1.3 Peptide Institute Adjuvant Peptide Introduction
11.1.4 Peptide Institute Revenue in Adjuvant Peptide Business (2017-2022)
11.1.5 Peptide Institute Recent Developments
11.2 Vivitide
11.2.1 Vivitide Company Details
11.2.2 Vivitide Business Overview
11.2.3 Vivitide Adjuvant Peptide Introduction
11.2.4 Vivitide Revenue in Adjuvant Peptide Business (2017-2022)
11.2.5 Vivitide Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Adjuvant Peptide Market Size Growth Rate by Purity (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Above 95%
Table 3. Key Players of Above 98%
Table 4. Global Adjuvant Peptide Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Adjuvant Peptide Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Adjuvant Peptide Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Adjuvant Peptide Market Share by Region (2017-2022)
Table 8. Global Adjuvant Peptide Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Adjuvant Peptide Market Share by Region (2023-2028)
Table 10. Adjuvant Peptide Market Trends
Table 11. Adjuvant Peptide Market Drivers
Table 12. Adjuvant Peptide Market Challenges
Table 13. Adjuvant Peptide Market Restraints
Table 14. Global Adjuvant Peptide Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Adjuvant Peptide Revenue Share by Players (2017-2022)
Table 16. Global Top Adjuvant Peptide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adjuvant Peptide as of 2021)
Table 17. Ranking of Global Top Adjuvant Peptide Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Adjuvant Peptide Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Adjuvant Peptide Product Solution and Service
Table 21. Date of Enter into Adjuvant Peptide Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Adjuvant Peptide Market Size by Purity (2017-2022) & (US$ Million)
Table 24. Global Adjuvant Peptide Revenue Market Share by Purity (2017-2022)
Table 25. Global Adjuvant Peptide Forecasted Market Size by Purity (2023-2028) & (US$ Million)
Table 26. Global Adjuvant Peptide Revenue Market Share by Purity (2023-2028)
Table 27. Global Adjuvant Peptide Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Adjuvant Peptide Revenue Share by Application (2017-2022)
Table 29. Global Adjuvant Peptide Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Adjuvant Peptide Revenue Share by Application (2023-2028)
Table 31. North America Adjuvant Peptide Market Size by Purity (2017-2022) & (US$ Million)
Table 32. North America Adjuvant Peptide Market Size by Purity (2023-2028) & (US$ Million)
Table 33. North America Adjuvant Peptide Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Adjuvant Peptide Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Adjuvant Peptide Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Adjuvant Peptide Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Adjuvant Peptide Market Size by Purity (2017-2022) & (US$ Million)
Table 38. Europe Adjuvant Peptide Market Size by Purity (2023-2028) & (US$ Million)
Table 39. Europe Adjuvant Peptide Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Adjuvant Peptide Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Adjuvant Peptide Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Adjuvant Peptide Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Adjuvant Peptide Market Size by Purity (2017-2022) & (US$ Million)
Table 44. Asia Pacific Adjuvant Peptide Market Size by Purity (2023-2028) & (US$ Million)
Table 45. Asia Pacific Adjuvant Peptide Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Adjuvant Peptide Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Adjuvant Peptide Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Adjuvant Peptide Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Adjuvant Peptide Market Size by Purity (2017-2022) & (US$ Million)
Table 50. Latin America Adjuvant Peptide Market Size by Purity (2023-2028) & (US$ Million)
Table 51. Latin America Adjuvant Peptide Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Adjuvant Peptide Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Adjuvant Peptide Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Adjuvant Peptide Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Adjuvant Peptide Market Size by Purity (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Adjuvant Peptide Market Size by Purity (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Adjuvant Peptide Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Adjuvant Peptide Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Adjuvant Peptide Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Adjuvant Peptide Market Size by Country (2023-2028) & (US$ Million)
Table 61. Peptide Institute Company Details
Table 62. Peptide Institute Business Overview
Table 63. Peptide Institute Adjuvant Peptide Product
Table 64. Peptide Institute Revenue in Adjuvant Peptide Business (2017-2022) & (US$ Million)
Table 65. Peptide Institute Recent Developments
Table 66. Vivitide Company Details
Table 67. Vivitide Business Overview
Table 68. Vivitide Adjuvant Peptide Product
Table 69. Vivitide Revenue in Adjuvant Peptide Business (2017-2022) & (US$ Million)
Table 70. Vivitide Recent Developments
Table 71. Research Programs/Design for This Report
Table 72. Key Data Information from Secondary Sources
Table 73. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Adjuvant Peptide Market Share by Purity: 2021 VS 2028
Figure 2. Above 95% Features
Figure 3. Above 98% Features
Figure 4. Global Adjuvant Peptide Market Share by Application: 2021 VS 2028
Figure 5. Scientific Research Case Studies
Figure 6. Medical Case Studies
Figure 7. Others Case Studies
Figure 8. Adjuvant Peptide Report Years Considered
Figure 9. Global Adjuvant Peptide Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Adjuvant Peptide Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Adjuvant Peptide Market Share by Region: 2021 VS 2028
Figure 12. Global Adjuvant Peptide Market Share by Players in 2021
Figure 13. Global Top Adjuvant Peptide Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adjuvant Peptide as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Adjuvant Peptide Revenue in 2021
Figure 15. North America Adjuvant Peptide Market Size YoY (2017-2028) & (US$ Million)
Figure 16. North America Adjuvant Peptide Market Size Market Share by Purity (2017-2028)
Figure 17. North America Adjuvant Peptide Market Size Market Share by Application (2017-2028)
Figure 18. North America Adjuvant Peptide Market Size Share by Country (2017-2028)
Figure 19. United States Adjuvant Peptide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Adjuvant Peptide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Adjuvant Peptide Market Size YoY (2017-2028) & (US$ Million)
Figure 22. Europe Adjuvant Peptide Market Size Market Share by Purity (2017-2028)
Figure 23. Europe Adjuvant Peptide Market Size Market Share by Application (2017-2028)
Figure 24. Europe Adjuvant Peptide Market Size Share by Country (2017-2028)
Figure 25. Germany Adjuvant Peptide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. France Adjuvant Peptide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. U.K. Adjuvant Peptide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Italy Adjuvant Peptide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Russia Adjuvant Peptide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Nordic Countries Adjuvant Peptide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Adjuvant Peptide Market Size YoY (2017-2028) & (US$ Million)
Figure 32. Asia Pacific Adjuvant Peptide Market Size Market Share by Purity (2017-2028)
Figure 33. Asia Pacific Adjuvant Peptide Market Size Market Share by Application (2017-2028)
Figure 34. Asia Pacific Adjuvant Peptide Market Size Share by Region (2017-2028)
Figure 35. China Adjuvant Peptide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Japan Adjuvant Peptide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. South Korea Adjuvant Peptide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Southeast Asia Adjuvant Peptide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. India Adjuvant Peptide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Australia Adjuvant Peptide Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 41. Latin America Adjuvant Peptide Market Size YoY (2017-2028) & (US$ Million)
Figure 42. Latin America Adjuvant Peptide Market Size Market Share by Purity (2017-2028)
Figure 43. Latin America Adjuvant Peptide Market Size Market Share by Application (2017-2028)
Figure 44. Latin America Adjuvant Peptide Market Size Share by Country (2017-2028)
Figure 45. Mexico Adjuvant Peptide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Brazil Adjuvant Peptide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Middle East & Africa Adjuvant Peptide Market Size YoY (2017-2028) & (US$ Million)
Figure 48. Middle East and Africa Adjuvant Peptide Market Size Market Share by Purity (2017-2028)
Figure 49. Middle East and Africa Adjuvant Peptide Market Size Market Share by Application (2017-2028)
Figure 50. Middle East and Africa Adjuvant Peptide Market Size Share by Country (2017-2028)
Figure 51. Turkey Adjuvant Peptide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Saudi Arabia Adjuvant Peptide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. UAE Adjuvant Peptide Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Peptide Institute Revenue Growth Rate in Adjuvant Peptide Business (2017-2022)
Figure 55. Vivitide Revenue Growth Rate in Adjuvant Peptide Business (2017-2022)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed


★調査レポート[アジュバントペプチドの世界市場インサイト・予測（～2028年）] (コード：QY22JLX09213)販売に関する免責事項を必ずご確認ください。
★調査レポート[アジュバントペプチドの世界市場インサイト・予測（～2028年）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 統合失調症関連ペプチドの世界市場インサイト・予測（～2028年）
  • 経口ペプチド薬の世界市場インサイト・予測（～2028年）
  • ガストリン放出ペプチドの世界市場インサイト・予測（～2028年）
  • 注射ペプチド薬の世界市場インサイト・予測（～2028年）
  • タンパク質＆ペプチド治療薬の世界市場インサイト・予測（～2028年）

    • ◆H&Iグローバルリサーチのお客様（例）◆